SCPHARMACEUTICALS INC. Debt Instrument, Convertible, Beneficial Conversion Feature
SCPHARMACEUTICALS INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $4.65 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-21.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2019-03-21
- SCPHARMACEUTICALS INC. debt instrument, convertible, beneficial conversion feature for fiscal 2016 was $4.65M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2016-12-31 | $4.65M 10-K · filed 2019-03-21 |